Detemir: Role in Type 1 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00564395|
Recruitment Status : Completed
First Posted : November 28, 2007
Results First Posted : July 17, 2018
Last Update Posted : July 17, 2018
|Study Design||Allocation: Randomized; Intervention Model: Crossover Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Type 1 Diabetes Mellitus
Drug: Insulin Detemir mixed with RAI injection
Drug: Insulin Detemir and RAI injection
|Recruitment Details||Eighteen participants were recruited for this trial. However, only 14 participants completed both study visits. Subjects were recruited from the clinics through fliers and online postings|
One male subject dropped out because of a very active sports schedule and could not continue participation.
Three subjects (two males and one female) had trouble with the Continuous Glucose Monitoring (CGM) tracing and, therefore, were excluded from the final analysis.